학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 2,651건 | 목록
1~20
Academic Journal
Ashlyn Y. Hersey; Paul A. S. Sheppard; Ryan Kim; Thu N. M. Pham; Laura López-Cruz; Timothy J. Bussey; Lisa M. Saksida
Scientific Reports, Vol 15, Iss 1, Pp 1-18 (2025)
Academic Journal
Humanity against the A-Bomb : An Analysis of the Countervailing Power of the Six Protagonists in John Hersey ' s Hiroshima. 53:49-69
Academic Journal
Matthew T. Turnley; Tabitha A. Hughes; Randy T. Larsen; Kent R. Hersey; Matthew S. Broadway; M. Colter Chitwood; W. Sue Fairbanks; Robert C. Lonsinger; Brock R. McMillan
Ecology and Evolution, Vol 14, Iss 7, Pp n/a-n/a (2024)
Academic Journal
McKelvey B; Friends of Cancer Research, Washington, District of Columbia.; Torres-Saavedra PA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Li J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Broeckx G; PA(2), Department of Pathology, Ziekenhuis aan de Stroom (ZAS), Antwerp, Belgium; Centre for Oncological Research (CORE), MIPPRO, Faculty of Medicine, Antwerp University, Antwerp, Belgium.; Deman F; PA(2), Department of Pathology, Ziekenhuis aan de Stroom (ZAS), Antwerp, Belgium; Centre for Oncological Research (CORE), MIPPRO, Faculty of Medicine, Antwerp University, Antwerp, Belgium.; Ali S; Lunit, Seoul, South Korea.; Andrews HS; Friends of Cancer Research, Washington, District of Columbia.; Arslan S; Panakeia Technologies, Cambridge, United Kingdom.; Azulay M; Nucleai, Chicago, Illinois.; Balasubramanian S; PathAI, Boston, Massachusetts.; Barrett JC; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Caie P; Indica Labs, Albuquerque, New Mexico.; Chen M; Caris Life Sciences, Irving, Texas.; Cohen D; GSK, Collegeville, Pennsylvania.; Dasgupta T; 4D Path, Newton, Massachusetts.; Fahrer D; Indica Labs, Albuquerque, New Mexico.; Green G; GA Green Consulting LLC, Newton, New Jersey.; Gustavson M; AstraZeneca, Gaithersburg, Maryland.; Hersey S; Bristol Myers Squibb, Lawrenceville, New Jersey.; Hidalgo-Sastre A; AstraZeneca Computational Pathology GmbH, AstraZeneca, Munich, Germany.; Jiwani S; Molecular Characterization Laboratory, Frederick National Laboratory/National Cancer Institute, Frederick, Maryland.; Joseph E; AstraZeneca, Waltham, Massachusetts.; Jung W; Lunit, Seoul, South Korea.; Kulig K; Kulig Consulting, New York, New York.; Kushnarev V; BostonGene, Waltham, Massachusetts.; Lennerz JK; BostonGene, Waltham, Massachusetts.; Li X; Emory University, Atlanta, Georgia.; Lodge M; Indica Labs, Albuquerque, New Mexico.; Mancuso J; Patient Advocate, Philadelphia, Pennsylvania.; Montalto M; Amgen, Thousand Oaks, California.; Mukhopadhyay S; 4D Path, Newton, Massachusetts.; Ntelemis F; Panakeia Technologies, Cambridge, United Kingdom.; Oberley M; Caris Life Sciences, Irving, Texas.; Pandya P; Panakeia Technologies, Cambridge, United Kingdom.; Puig O; Nucleai, Chicago, Illinois.; Richardson ET; Merck & Co Inc, Boston, Massachusetts.; Sarachakov A; BostonGene, Waltham, Massachusetts.; Stewart M; Friends of Cancer Research, Washington, District of Columbia. Electronic address: mstewart@focr.org.; McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Salgado R; PA(2), Department of Pathology, Ziekenhuis aan de Stroom (ZAS), Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia.; Allen J; Friends of Cancer Research, Washington, District of Columbia.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE
Academic Journal
Matthew T. Turnley; Randy T. Larsen; Tabitha A. Hughes; Morgan S. Hinton; Daniel W. Sallee; Sydney Lamb; Kent R. Hersey; Brock R. McMillan
Animal Biotelemetry, Vol 10, Iss 1, Pp 1-8 (2022)
Academic Journal
A. J. Wood; C. H. Lin; M. Li; K. Nishtala; S. Alaei; F. Rossello; C. Sonntag; L. Hersey; L. B. Miles; C. Krisp; S. Dudczig; A. J. Fulcher; S. Gibertini; P. J. Conroy; A. Siegel; M. Mora; P. Jusuf; N. H. Packer; P. D. Currie
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Academic Journal
Hersey S; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.; McGuire K; Regeneron, Tarrytown, New York, United States.; Kholmanskikh O; Belgium FAMHP/EU EMA, Brussels, Belgium.; Bivi N; Lilly, Indianapolis, Indiana, United States.; Bandukwala A; US FDA, Silver Spring, Maryland, United States.; Gong B; US FDA, Jefferson, Arkansas, United States.; Irwin C; Health Canada, Ottawa, Ontario, Canada.; Ray S; Dyne Therapeutics, Waltham, Massachusetts, United States.; Gunsior M; Astria Therapeutics, Gaithersburg, Maryland, United States.; Avanesov A; Moderna, Cambridge, Massachusetts, United States.; Baker B; Regeneron, Argyle, Texas, United States.; Bond S; Alnylam, Cambridge, Massachusetts, United States.; Braun A; Takeda, Cambridge, Massachusetts, United States.; Buoninfante A; EU EMA, Amsterdam, Netherlands.; Dessy F; GlaxoSmithKline, Rixensart, Belgium.; Fang X; ASKBIO, Durham, North Carolina, United States.; Garofolo F; BRI Frontage, Vancouver, British Columbia, Canada.; Gomme E; Pfizer, Pearl River, New York, United States.; Hays A; Bioagilytix, Durham, North Carolina, United States.; King L; Pfizer, Cambridge, Massachusetts, United States.; Mayer C; Austria AGES/ EU EMA, Vienna, Austria.; McGregor J; WRIB, Toronto, Ontario, Canada.; McHenry M; Regeneron, Tarrytown, New York, United States.; Nowocin A; UK MHRA, London, United Kingdom.; Rubel C; Biogen, Cambridge, Massachusetts, United States.; Sanderink G; Sanofi R&D, Cambridge, Massachusetts, United States.; Scott B; Health Canada, Ottawa, Ontario, Canada.; Scully I; Pfizer, Pearl River, New York, United States.; Seyda A; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.; Stoop J; Johnson & Johnson, Leiden, the Netherlands.; Tang H; GlaxoSmithKline, Collegeville, Pennsylvania, United States.; Neto JT; Brazil ANVISA, Brasilia, Brazil.; Walravens K; GlaxoSmithKline, Rixensart, Belgium.; Wang K; Pfizer, Pearl River, New York, United States.; Wassmer S; Health Canada, Ottawa, Ontario, Canada.; Xiao W; US FDA, Silver Spring, Maryland, United States.; Zhu L; Moderna, Cambridge, Massachusetts, United States.; Zoghbi J; Biogen, Cambridge, Massachusetts, United States.; Brockus C; Lilly, Indianapolis, Indiana, United States.; Petit-Frere C; Fresenius Kabi SwissBioSim GmbH, Eysins, Switzerland.; Coble K; Boehringer Ingelheim, Ridgefield, Connecticut, United States.; Fischer S; Genentech, South San Francisco, California, United States.; Yearwood G; Bristol Myers Squibb, Hellertown, Pennsylvania, United States.; Cao L; Sangamo Therapeutics, Richmond, California, United States.; Dysinger M; Alexion Pharmaceuticals, Killingworth, Connecticut, United States.; Grimaldi C; Regeneron, Tarrytown, New York, United States.; Jiang Y; Bioanalytical Discovery and Development Sciences, Johnson & Johnson, Spring House, Pennsylvania, United States.; Joyce A; Pfizer, Andover, Massachusetts, United States.; Kerridge C; UK MHRA, London, United Kingdom.; Lu K; Regeneron, Tarrytown, New York, United States.; McCush F; Pfizer, Chesterfield, Missouri, United States.; Nolan K; Merck, Lower Gwynedd, Pennsylvania, United States.; Connor EO; AstraZeneca, Gaithersburg, Maryland, United States.; Palmer R; Sanofi R&D, Cambridge, Massachusetts, United States.; Reese K; GlaxoSmithKline, Collegeville, Pennsylvania, United States.; Stubenrauch KG; Roche Diagnostics GmbH, Penzberg, Germany.; Verch T; Merck, Lower Gwynedd, Pennsylvania, United States.; Beaver C; Daiichi Sankyo, Somerville, Massachusetts, United States.; Mendez L; Merck & Co., Rahway, New Jersey, United States.; Decman V; GlaxoSmithKline, Collegeville, Pennsylvania, United States.; Bhavaraju K; Dr. Reddy's Laboratories Ltd., Hyderabad, India.; Huleatt J; Gates Medical Research Institute, Cambridge, Massachusetts, United States.; Trampont PC; Moderna, Cambridge, Massachusetts, United States.; Eck S; AstraZeneca, Gaithersburg, Maryland, United States.; Goihberg P; Pfizer, Andover, Massachusetts, United States.; Alcaide EG; Roche, Basel, Switzerland.; Hedrick MN; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.; Jalah R; Bioanalytical Discovery and Development Sciences, Johnson & Johnson, Spring House, Pennsylvania, United States.; McGrath S; Moderna, Cambridge, Massachusetts, United States.; Ogorman W; Genentech, South San Francisco, California, United States.; Prior S; UK MHRA, London, United Kingdom.; Sehra S; Incyte Corporation, Wilmington, Delaware, United States.; Shaik S; Takeda, Burlington, Massachusetts, United States.; Standifer N; Tempest, Brisbane, California, United States.; Stevens C; Pfizer, Andover, Massachusetts, United States.; Stevens E; Pfizer, Groton, Connecticut, United States.; Sun YS; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE
Conference
Chen, S.; du Toit, C.; Hersey, K.; Pao, D.; Karasack, V.; Patel, J.; Ramesh, M.; Sui, C.; Ekelman, E.
IEEE Antennas and Propagation Society International Symposium. 2001 Digest. Held in conjunction with: USNC/URSI National Radio Science Meeting (Cat. No.01CH37229) Antennas and Propagation - APS 2001 Antennas and Propagation Society International Symposium, 2001. IEEE. 3:808-811 vol.3 2001
Academic Journal
Guerrero-Torres L; Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.; Shroff ZC; Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland shroffz@who.int.; Hanefeld J; Robert Koch Institut, Berlin, Germany.; Lee VJ; Interim Communicable Diseases Agency (iCDA), Singapore.; Lynes S; International Association of National Public Health Institutes (IANPHI), Brussels, Belgium.; Muvunyi C; Rwanda Biomedical Center, Kigali, Rwanda.; Namara G; Collaborative Intelligence, World Health Organization, Health Emergencies Programme, Berlin, Germany.; Raji T; Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.; Zuber A; Ata Health Strategies, Washington, District of Columbia, USA.; Hersey S; Collaborative Intelligence, World Health Organization, Health Emergencies Programme, Berlin, Germany.; Rasanathan K; Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101685275 Publication Model: Electronic Cited Medium: Print ISSN: 2059-7908 (Print) Linking ISSN: 20597908 NLM ISO Abbreviation: BMJ Glob Health Subsets: MEDLINE; In Process
Academic Journal
Jalloh, MF; Kaiser, R; Diop, M; Jambai, A; Redd, JT; Bunnell, RE; Castle, E; Alpren, C; Hersey, S; Ekstrom, AM
PLOS NEGLECTED TROPICAL DISEASES. 14(8):e0008624-e0008624
Academic Journal
بازیابی دانش و نظامهای معنایی, Vol 10, Iss 34, Pp 59-98 (2023)
Academic Journal
Boyiadzis M; Genentech, South San Francisco, California, USA.; Wei AH; Peter MacCallum Cancer Center and Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Paiva B; Cancer Center Clinica Universidad de Navarra, Cima Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.; Freeman SD; Institute of Immunology and Immunotherapy, College of Medical and Health, University of Birmingham, Birmingham, UK.; Kaspers G; Princess Máxima Cancer Center for Pediatric Oncology, Utrecht, Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Netherlands.; Chyla B; AbbVie, North Chicago, Illinois, USA.; Hersey S; Translational Sciences and Diagnostics, Bristol Myers Squibb, Summit, New Jersey, USA.; Patel R; Johnson and Johnson Innovative Medicine, Global Regulatory Affairs, High Wycombe, Buckinghamshire, UK.; Maloney B; Regulatory Affairs, Johnson and Johnson, New Brunswick, New Jersey, USA.; Blanchet Zumofen MH; F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Van Hoef M; Novartis Pharmaceuticals AG, Basel, Switzerland.; Wulff B; F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Obourn V; Oncology Medicine, Novartis Corporation, Cambridge, Massachusetts, USA.; Patel S; Precision Medicine and Companion Diagnostic, Bristol Myers Squibb, Greenwich, Connecticut, USA.; Lopes de Menezes D; Translational Medicine, Hematology, Bristol Myers Squibb, Brisbane, California, USA.; Shi Q; Department of Quantitative Health Science, Mayo Clinic, Rochester, Minnesota, USA.; Bengoudifa BR; Bristol Myers Squibb, Boudry, Switzerland.; Dimier N; Early Oncology Development, F. Hoffmann-La Roche Ltd., London, UK.; Prior TJ; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.; Roboz GJ; Clinical and Translational Leukemia Program, Weill Cornell Medicine and New York Presbyterian Hospital, New York, New York, USA.; Prebet T; Clinical Development, Bristol Myers Squibb, Madison, New Jersey, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Editorial & Opinion
Rasanathan K; Director E; Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.; Hersey S; Director D; Collaborative Intelligence, World Health Organization, Health Emergencies Programme, Berlin, Germany.; Shroff ZC; Head A I U; Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.; Namara G; Officer CS; Collaborative Intelligence, World Health Organization, Health Emergencies Programme, Berlin, Germany.
Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE; In Process
Academic Journal
Linh T. Nguyen; Charlotte S. Lo; Michael Fyrsta; Jessica Nie; Jennifer Y. Yam; Pei-Hua Yen; Michael X. Le; Karen Hersey; Miran Kenk; Megan Crumbaker; Neil Fleshner; Girish Kulkarni; Robert Hamilton; Michael Jewett; Antonio Finelli; Andrew Evans; Joan Sweet; Pamela S. Ohashi; Anthony M. Joshua
Prostate Cancer, Vol 2022 (2022)
검색 결과 제한하기
제한된 항목
[검색어] Hersey, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어